Senti Biosciences, Inc.
SNTI
$1.65
$0.0553.46%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.40% | -2,213.44% | 97.89% | -157.66% | 7.50% |
| Total Depreciation and Amortization | -1.30% | -36.53% | -0.34% | 50.77% | -1.32% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 29.98% | 109.34% | -178.20% | 1,700.87% | 9.65% |
| Change in Net Operating Assets | 60.40% | -41.74% | -147.88% | 4.46% | 398.63% |
| Cash from Operations | 6.95% | -4.04% | -71.68% | 5.74% | 28.57% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -118.33% | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 490,390.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 215.22% | -118.47% | -7.78% | -- | -- |
| Cash from Financing | 344.20% | -100.81% | 2,002.05% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 15.33% | -138.29% | 803.97% | 35.70% | 28.66% |